146 related articles for article (PubMed ID: 37452997)
21. C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic.
Ravindran A; Fervenza FC; Smith RJH; De Vriese AS; Sethi S
Mayo Clin Proc; 2018 Aug; 93(8):991-1008. PubMed ID: 30077216
[TBL] [Abstract][Full Text] [Related]
22. Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis.
Blom AM; Corvillo F; Magda M; Stasiłojć G; Nozal P; Pérez-Valdivia MÁ; Cabello-Chaves V; Rodríguez de Córdoba S; López-Trascasa M; Okrój M
J Clin Immunol; 2016 Jul; 36(5):517-27. PubMed ID: 27146825
[TBL] [Abstract][Full Text] [Related]
23. Asymptomatic poststreptococcal glomerulonephritis in relatives of patients with symptomatic glomerulonephritis. Diagnostic value of endostreptosin antibodies.
Lange K; Azadegan AA; Seligson G; Bovie RC; Majeed H
Child Nephrol Urol; 1988-1989; 9(1-2):11-5. PubMed ID: 3251614
[TBL] [Abstract][Full Text] [Related]
24. Cooccurrence of Alport syndrome and poststreptococcal acute glomerulonephritis with improvement after steroid administration.
Suzuki R; Hayashi A; Endo M; Ueda Y; Takahashi T; Sato Y; Okamoto T
CEN Case Rep; 2022 Nov; 11(4):453-457. PubMed ID: 35397771
[TBL] [Abstract][Full Text] [Related]
25. C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases.
Zhao F; Afonso S; Lindner S; Hartmann A; Löschmann I; Nilsson B; Ekdahl KN; Weber LT; Habbig S; Schalk G; Kirschfink M; Zipfel PF; Skerka C
Front Immunol; 2019; 10():1030. PubMed ID: 31214159
[TBL] [Abstract][Full Text] [Related]
26. Poststreptococcal acute glomerulonephritis superimposed on bilateral renal hypoplasia.
Naito-Yoshida Y; Hida M; Maruyama Y; Hori N; Awazu M
Clin Nephrol; 2005 Jun; 63(6):477-80. PubMed ID: 15960150
[TBL] [Abstract][Full Text] [Related]
27. C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.
Ruggenenti P; Daina E; Gennarini A; Carrara C; Gamba S; Noris M; Rubis N; Peraro F; Gaspari F; Pasini A; Rigotti A; Lerchner RM; Santoro D; Pisani A; Pasi A; Remuzzi G;
Am J Kidney Dis; 2019 Aug; 74(2):224-238. PubMed ID: 30929851
[TBL] [Abstract][Full Text] [Related]
28. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
Frémeaux-Bacchi V; Weiss L; Brun P; Kazatchkine MD
Nephrol Dial Transplant; 1994; 9(7):811-4. PubMed ID: 7970124
[TBL] [Abstract][Full Text] [Related]
29. Human anti-idiotypic antibody responses to autoantibody against the alternative pathway C3 convertase.
Spitzer RE; Stitzel AE; Tsokos GC
Clin Immunol Immunopathol; 1990 Oct; 57(1):19-31. PubMed ID: 2394034
[TBL] [Abstract][Full Text] [Related]
30. Evidence that production of autoantibody to the alternative pathway C3 convertase is a normal physiologic event.
Spitzer RE; Stitzel AE; Tsokos GC
J Pediatr; 1990 May; 116(5):S103-8. PubMed ID: 2329411
[TBL] [Abstract][Full Text] [Related]
31. A CHILD WITH DENSE DEPOSIT DISEASE AND DECREASED CLASSIC COMPLEMENT PATHWAY ACTIVITY.
Trutin I; Oletić L; Galešić Ljubanović D; Turudić D; Milošević D
Acta Clin Croat; 2021 Mar; 60(1):141-145. PubMed ID: 34588735
[TBL] [Abstract][Full Text] [Related]
32. Poststreptococcal acute glomerulonephritis can be a risk factor for accelerating kidney dysfunction in Alport syndrome: a case experience.
Araki Y; Kawaguchi A; Sakakibara N; Nagaoka Y; Yamamura T; Horinouchi T; Nagano C; Morisada N; Iijima K; Nozu K
CEN Case Rep; 2020 Nov; 9(4):418-422. PubMed ID: 32592137
[TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohort.
Michels MAHM; Wijnsma KL; Kurvers RAJ; Westra D; Schreuder MF; van Wijk JAE; Bouts AHM; Gracchi V; Engels FAPT; Keijzer-Veen MG; Dorresteijn EM; Volokhina EB; van den Heuvel LPWJ; van de Kar NCAJ
Pediatr Nephrol; 2022 Mar; 37(3):601-612. PubMed ID: 34476601
[TBL] [Abstract][Full Text] [Related]
34. Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations.
Corvillo F; Okrój M; Nozal P; Melgosa M; Sánchez-Corral P; López-Trascasa M
Front Immunol; 2019; 10():886. PubMed ID: 31068950
[TBL] [Abstract][Full Text] [Related]
35. Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement.
Sethi S; Fervenza FC; Zhang Y; Zand L; Meyer NC; Borsa N; Nasr SH; Smith RJ
Kidney Int; 2013 Feb; 83(2):293-9. PubMed ID: 23235567
[TBL] [Abstract][Full Text] [Related]
36. Successful therapy of C3Nef-positive C3 glomerulopathy with plasma therapy and immunosuppression.
Häffner K; Michelfelder S; Pohl M
Pediatr Nephrol; 2015 Nov; 30(11):1951-9. PubMed ID: 25986912
[TBL] [Abstract][Full Text] [Related]
37. Superimposition of poststreptococcal acute glomerulonephritis on the course of IgA nephropathy.
Hiki Y; Tamura K; Shigematsu H; Kobayashi Y
Nephron; 1991; 57(3):358-64. PubMed ID: 2017279
[TBL] [Abstract][Full Text] [Related]
38. [A case of crescentic poststreptococcal acute glomerulonephritis (PSAGN) accompanied by membranous nephropathy].
Matsuda J; Nagayama I; Yamaguchi Y; Itano S; Mori D; Imakita N; Takeji M; Yamauchi A
Nihon Jinzo Gakkai Shi; 2013; 55(4):567-73. PubMed ID: 23819387
[TBL] [Abstract][Full Text] [Related]
39. Acute poststreptococcal glomerulonephritis superimposed on IgA nephropathy.
Lim BJ; Suh KS; Na KR; Lee KW; Shin YT
Clin Nephrol; 2008 Aug; 70(2):155-8. PubMed ID: 18793531
[TBL] [Abstract][Full Text] [Related]
40. C3 nephritic factor can be associated with membranous glomerulonephritis.
Niel O; Dallocchio A; Thouret MC; Guigonis V; Cassuto É; Frémeaux-Bacchi V; Bérard É
Pediatr Nephrol; 2015 Feb; 30(2):353-5. PubMed ID: 25395361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
